Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Bio SB now offers HRP Green, a vibrant chromogen to help clinical and research laboratories detect IHC markers on paraffin-embedded tissues. HRP Green comes in a two-part buffer and chromogen format that is compatible with all Bio SB polymer and biotin HRP-based detection systems. HRP Green requires a five-minute incubation period, can be counterstained with Nuclear Fast Red or hematoxylin, and is xylene (PermaMounter) compatible.
August 2013—Vector Laboratories now offers glycoprotein eluting solutions and neoglycoproteins. Five glycoprotein eluting solutions have been generated to complement the company’s range of agarose-bound lectins. These solutions maximize the yield of eluted glycoproteins from the beads and preserve lectin activity for repeat use.
Hamilton Robotics has a new module for its Microlab Star workstation that automates enzyme-linked immunoabsorbant assays (ELISAs). The ELISA StarLet module integrates precision liquid handling instrumentation with multiple devices and sophisticated software.
Leica Biosystems, in partnership with Indica Labs, has launched the HALO next-generation image-analysis software. The HALO platform is fast, scalable, and user-friendly and is for Aperio ePathology image analysis.
Beckman Coulter’s Microfuge 20 and 20R microcentrifuges are designed to meet the specific requirements of a range of research applications and are easy to use. Paired with Microfuge series rotors, the microcentrifuges provide flexibility and reliable, precise performance while occupying a small footprint.
Ventana Medical Systems has signed a worldwide agreement with health care imaging expert Barco to provide Barco’s diagnostic and clinical review display systems for use with Ventana’s Virtuoso image and workflow management system.
Health Canada has approved Life Technologies’ Applied Biosystems 3500 Dx/3500xL Dx genetic analyzers CS2 for diagnostic use. The Applied Biosystems 3500 Dx series genetic analyzers deliver high-quality performance, high throughput, and increased productivity for clinical laboratories. The 3500xL Dx is an automated 24-capillary-based Sanger sequencer; the 3500 Dx is an eight-capillary instrument.
PathCentral announced that Johns Hopkins University School of Medicine’s Department of Pathology will participate as a client in the PathCentral Pathology Network (www.pathcentralpro.net), a comprehensive online information exchange and digital consultation forum.
MDxHealth announced data showing that methylation of the DCR1 gene may help guide oncologists in selecting metastatic colorectal cancer patients to receive irinotecan-based therapy. The data, presented at this year’s ASCO meeting, showed that CRC patients with methylated DCR1 did not benefit from the addition of irinotecan to capecitabine therapy.
EKF Diagnostics’ Stat-Site M Hgb is a portable hemoglobin photometer. The pocket-sized device provides accurate hemoglobin analysis results within 30 seconds from 15 µL of whole blood.
